MFS
CYTK icon

MSI Financial Services’s Cytokinetics CYTK Stock Holding History

MSI Financial Services’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$17K Buy
+1,375
New +$14.6K ﹤0.01% 2485
2014
Q1 		– Sell
-2
Closed – – 2524
2013
Q4 		$0 Buy
+2
New +$13 ﹤0.01% 2506

Other funds holding CYTK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

MSI Financial Services's CYTK Position: Q4 2016 in Review

MSI Financial Services opened a new position in Cytokinetics (CYTK) in Q4 2016: 1,375 shares worth $17K. The stake represents ﹤0.01% of the portfolio and ranks #2485 among its holdings. This is a return to the name: MSI Financial Services previously reported a position in CYTK as recently as Q4 2013.

MSI Financial Services first reported a position in CYTK in Q4 2013 and has held it in 2 quarters since. 101 funds tracked by Wall St. Rank hold CYTK as of Q4 2016.

  • MSI Financial Services held 1,375 shares of Cytokinetics worth $17K as of Q4 2016.
  • Cytokinetics was a new MSI Financial Services position in Q4 2016.
  • Cytokinetics made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #2485 holding.
  • MSI Financial Services first reported a position in Cytokinetics in Q4 2013 and has held it in 2 quarters since.
  • 101 funds tracked by Wall St. Rank held Cytokinetics as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.